Thrombophilia in children with venous thromboembolic disease

Shoshana Revel-Vilk1, Gili Kenet

  • 1Pediatric Hematology/Oncology Unit, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem il-91200, Israel. shoshanav@hadassah.org.il

Thrombosis Research
|July 5, 2005
PubMed

Insights

Thrombophilia significantly contributes to childhood venous thromboembolic events (VTEs), with prevalence varying widely. Current guidelines recommend broad testing, but re-evaluating risk factors and prognostic value may refine future management strategies.

Area of Science:

  • Pediatric Hematology
  • Thrombosis and Hemostasis
  • Clinical Genetics

Background:

  • Childhood venous thromboembolic events (VTEs) are often linked to underlying conditions like central venous lines, cancer, and cardiac diseases.
  • The prevalence of thrombophilia in pediatric VTE cases shows extreme variation (10-78%) across different studies.
  • This variability likely stems from differences in patient populations and study methodologies.

Purpose of the Study:

  • To review the significance of thrombophilia in the development of VTE in children.
  • To discuss the implications of thrombophilia testing and its impact on long-term VTE management in pediatric patients.

Main Methods:

  • Literature review focusing on thrombophilia and childhood VTE.
  • Analysis of reported prevalence rates and influencing factors.
  • Discussion of current diagnostic and management guidelines.

Main Results:

  • Thrombophilia is a notable factor in childhood VTE, but its precise contribution is inconsistently reported.
  • Initial VTE management in children with thrombophilia generally mirrors that of non-thrombophilic patients, with exceptions for rare homozygous protein deficiencies.
  • The long-term therapeutic impact and prognostic value of thrombophilic markers in pediatric VTE remain unclear.

Conclusions:

  • Current guidelines advocate comprehensive thrombophilia screening for all children with VTE.
  • Re-evaluation of comorbid risk factors and the prognostic significance of thrombophilic markers is needed.
  • Future approaches to managing pediatric VTE may benefit from more individualized and less rigid treatment schemes based on a thorough risk assessment.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...